Open AccessAbstract 3: Metronomic chemotherapy with cyclophosphamide (Cy) and the repositioned drug losartan (Los) for the treatment of M-234p triple negative murine mammary adenocarcinoma
Author(s) -
Julián Guercetti,
Leandro E. Mainetti,
Monica Carolina Grillo,
Antonela Del Giúdice,
María Virginia Baglioni,
Juan Manuel Cáceres,
Ainelén Arboatti,
Daniel E. Francés,
Viviana R. Rozados,
María José Rico,
O. Graciela Scharovsky
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3
Subject(s) - medicine , losartan , flow cytometry , cyclophosphamide , apoptosis , immunohistochemistry , cd8 , chemotherapy , antagonist , tunel assay , pharmacology , endocrinology , immune system , receptor , immunology , angiotensin ii , biology , biochemistry